Bredt David sold RAPP
January 15, 2026 · Form 4 insider transaction
Bredt David sold 200 shares of Rapport Therapeutics, Inc. at $27.40 per share, a transaction worth $5.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
200
Price
$27.40
Total value
$5.5K
InsiderBredt David
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 15, 2026
Filing dateJanuary 16, 2026
Shares owned after395,575
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 12, 2024.